Skip to main content

Table 3 Evolution of functional performance between M0 and M6

From: Schizophrenia-spectrum patients treated with long-acting injectable risperidone in real-life clinical settings: functional recovery in remitted versus stable, non-remitted patients (the EVeREST prospective observational cohort study)

  M0 M6 M6-M0 p
(N = 1490) (N = 1354)
GAF rating scorea 46.4 ± 0.54 52.2 ± 0.67 5.8 ± 0.45 < 0.001
Social functioning rating scoreb 18.3 ± 0.11 20.2 ± 0.12 1.9 ± 0.10 < 0.001
 Social skills 11.4 ± 0.06 12.5 ± 0.07 1.1 ± 0.07 < 0.001
 Social roles 6.90 ± 0.05 7.73 ± 0.06 0.83 ± 0.05 < 0.001
  1. Values are given as mean ± SEM. M0, month 0 (inclusion). M6, month 6 (end of study)
  2. aMaximum GAF rating score = 100
  3. bSocial functioning rating scores = total (from 7 to 28), social skills (from 4 to 6) and social roles (from 3 to 12)